Gastric Neuroendocrine Tumors - From Clinicopathologic to Immunophenotype Features

#1435

Introduction: Type 3 Gastric Neuroendocrine tumors (GNET3) natured in the absence of a specific gastric background of pathologic changes, while with poorer outcome due to a high rate of distant metastasis.

Aim(s): To investigate a potential effective therapy for GNET3.

Materials and methods: We retrospectively observed 16 cases of GNET3 treated in our hospital, including 12 surgical cases and 4 endoscopic submucosal dissection (ESD) cases from 2005 to 2014.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Ji Y, Xie Y, Sun Y, Wang H, Chen S,

Keywords: gastric, neuroendocrine tumor, mTOR,

To read the full abstract, please log into your ENETS Member account.